Language

News topic

Product Myatorlip

Current shortage notices for the product family Myatorlip, structured by product, country and reporting period.

6 notices

← All shortages

What the Myatorlip notices indicate for the supply chain

The 6 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Myatorlip 10 mg - 10 mg film-coat. tabl. 90

Active ingredient: Ezetimibe ,Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 20 mg film-coat. tabl. 90

Active ingredient: Ezetimibe ,Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 10 mg filmomh. tabl. 90

Active ingredient: Ezetimibe ; Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 20 mg filmomh. tabl. 90

Active ingredient: Ezetimibe ; Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 40 mg filmomh. tabl. 90

Active ingredient: Ezetimibe ; Atorvastatin

View notice details →
Belgium

Myatorlip 10 mg - 80 mg filmomh. tabl. 90

Active ingredient: Ezetimibe ; Atorvastatin

View notice details →